Sera Prognostics, Inc. (SERA)
USD 2.91
(-0.68%)
USD 2.91
(-0.68%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 95.44 Million USD | -17.96% |
| 2022 | 116.32 Million USD | -20.88% |
| 2021 | 147.02 Million USD | 893.71% |
| 2020 | 14.79 Million USD | -36.39% |
| 2019 | 23.25 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 89.88 Million USD | -5.82% |
| 2024 Q2 | 84.86 Million USD | -5.59% |
| 2023 Q4 | 95.44 Million USD | 5.98% |
| 2023 Q2 | 96.68 Million USD | -8.46% |
| 2023 FY | 95.44 Million USD | -17.96% |
| 2023 Q1 | 105.61 Million USD | -9.21% |
| 2023 Q3 | 90.05 Million USD | -6.85% |
| 2022 Q2 | 125.05 Million USD | -7.27% |
| 2022 FY | 116.32 Million USD | -20.88% |
| 2022 Q1 | 134.86 Million USD | -8.27% |
| 2022 Q3 | 116.56 Million USD | -6.79% |
| 2022 Q4 | 116.32 Million USD | -0.2% |
| 2021 Q2 | 95.06 Million USD | 51.52% |
| 2021 Q3 | 153.68 Million USD | 61.66% |
| 2021 Q4 | 147.02 Million USD | -4.33% |
| 2021 FY | 147.02 Million USD | 893.71% |
| 2021 Q1 | 62.74 Million USD | 324.06% |
| 2020 FY | 14.79 Million USD | -36.39% |
| 2020 Q4 | 14.79 Million USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2019 FY | 23.25 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | 197.4 Million USD | 51.652% |
| Applied DNA Sciences, Inc. | 13.65 Million USD | -599.121% |
| Aspira Women's Health Inc. | 6.26 Million USD | -1424.13% |
| Biodesix, Inc. | 99.09 Million USD | 3.688% |
| BioNexus Gene Lab Corp. | 11.39 Million USD | -737.217% |
| bioAffinity Technologies, Inc. | 8.22 Million USD | -1060.864% |
| bioAffinity Technologies, Inc. | 8.22 Million USD | -1060.864% |
| Bionano Genomics, Inc. | 214.4 Million USD | 55.485% |
| CareDx, Inc | 484.61 Million USD | 80.306% |
| Check-Cap Ltd. | 25.01 Million USD | -281.505% |
| Castle Biosciences, Inc. | 477.81 Million USD | 80.025% |
| DarioHealth Corp. | 96.38 Million USD | 0.984% |
| Exact Sciences Corporation | 6.47 Billion USD | 98.525% |
| Fulgent Genetics, Inc. | 1.27 Billion USD | 92.503% |
| Guardant Health, Inc. | 1.78 Billion USD | 94.657% |
| ICON Public Limited Company | 16.98 Billion USD | 99.438% |
| IDEXX Laboratories, Inc. | 3.25 Billion USD | 97.072% |
| Illumina, Inc. | 10.11 Billion USD | 99.056% |
| Intelligent Bio Solutions Inc. | 13.77 Million USD | -592.662% |
| iSpecimen Inc. | 15.81 Million USD | -503.326% |
| Standard BioTools Inc. | 323.06 Million USD | 70.458% |
| MDxHealth SA | 129.13 Million USD | 26.09% |
| 23andMe Holding Co. | 395.16 Million USD | 75.848% |
| Medpace Holdings, Inc. | 1.65 Billion USD | 94.24% |
| Myriad Genetics, Inc. | 1.19 Billion USD | 92.038% |
| Mainz Biomed B.V. | 15.4 Million USD | -519.384% |
| ENDRA Life Sciences Inc. | 6.75 Million USD | -1313.073% |
| NeoGenomics, Inc. | 1.68 Billion USD | 94.323% |
| Neogen Corporation | 4.58 Billion USD | 97.918% |
| Inotiv, Inc. | 856.53 Million USD | 88.857% |
| Natera, Inc. | 1.45 Billion USD | 93.45% |
| OPKO Health, Inc. | 2.01 Billion USD | 95.256% |
| Psychemedics Corporation | 13.27 Million USD | -619.224% |
| Prenetics Global Limited | 254.17 Million USD | 62.45% |
| Prenetics Global Limited | 254.17 Million USD | 62.45% |
| Precipio, Inc. | 18.1 Million USD | -427.269% |
| Personalis, Inc. | 225.09 Million USD | 57.6% |
| RadNet, Inc. | 2.88 Billion USD | 96.694% |
| Sotera Health Company | 3.13 Billion USD | 96.951% |
| Neuronetics, Inc. | 115.83 Million USD | 17.603% |
| Star Equity Holdings, Inc. | 86.97 Million USD | -9.735% |
| Star Equity Holdings, Inc. | 86.97 Million USD | -9.735% |
| Trinity Biotech plc | 59.43 Million USD | -60.58% |
| Twist Bioscience Corporation | 776.4 Million USD | 87.707% |
| Exagen Inc. | 56.94 Million USD | -67.605% |